FIDSON Share Price Performance
₦42.30
26.55 (168.57%)
20.9% overvalued intrinsic discount
₦35.00
Fair Value
Price ₦42.30
Wane_Investment_House ₦35.00
Fair Value₦35.00
Share Price₦42.30
20.9% overvalued intrinsic discount
Fidson Healthcare Plc Stock Price
- 1 Narratives written by author
- 4 Comments on narratives written by author
- 20 Fair Values set on narratives written by author
FIDSON Community Narratives
WA
Fair Value ₦35 20.9% overvalued intrinsic discount
Fidson Healthcare Plc – H1 2025
3users have liked this narrative
4users have commented on this narrative
9users have followed this narrative
Fidson Healthcare Plc – H1 2025
Fidson Healthcare Plc delivered a strong top-line performance in H1 2025, recording a 68% YoY increase in revenue from ₦37.3 billion to ₦62.6 billion. Despite facing macroeconomic challenges including rising finance costs and exchange rate volatility, the company grew its profit after tax by nearly 4x, reaching ₦6.02 billion (vs.
3users have liked this narrative
4users have commented on this narrative
9users have followed this narrative
WA
₦35
20.9% overvalued intrinsic discount
Wane_Investment_House Fair Value
Revenue growth
4.39% p.a.
Profit Margin
12%
Future PE
10.35x
Share price in 2028
₦67.46
Snowflake Analysis
Fidson Healthcare Plc Key Details
About FIDSON
- Founded
- 1995
- Employees
- 674
- CEO
- WebsiteView website
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered in Lagos, Nigeria.